You are here

Foam-in-Place Contaminant Containment System

Award Information
Agency: National Aeronautics and Space Administration
Branch: N/A
Contract: NNX09CE10P
Agency Tracking Number: 084545
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: S5.02
Solicitation Number: N/A
Timeline
Solicitation Year: 2008
Award Year: 2009
Award Start Date (Proposal Award Date): 2009-01-22
Award End Date (Contract End Date): 2009-07-22
Small Business Information
9621 Camino Del Sol NE
Albuquerque, NM 87111-1522
United States
DUNS: 859106296
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Andrea Hoyt Haight
 Principal Investigator
 (505) 346-1685
 adherenttech@comcast.net
Business Contact
 Susan Switzer
Title: Business Official
Phone: (505) 346-1685
Email: adherenttech@comcast.net
Research Institution
N/A
Abstract

Over the next few decades, NASA plans to launch a number of planetary probes to and return the samples to Earth for detailed investigation. Due to the rapid expanse of space exploration, a need has been identified for the proper handling of extraterrestrial samples. Not only must the sample return system maintain the physical integrity of the sample in sometimes rigorous conditions (e.g., rover driving loads, diurnal temperature fluctuations, cruise, atmospheric entry and impact), it must address potential contamination issues. The samples themselves can become contaminated and they also present a serious contamination danger to the Earth. Therefore, the highest possible level of precaution must be exercised when handling the outer space samples until there are studies proving them harmless.
In this Phase I project, we are proposing a "foam-in-the-capsule" system for containing and encapsulating samples of extraterrestrial material to be returned to Earth for detailed study. The system will eliminate or dramatically reduce the risk of contamination on flight hardware and ease the handling of the sample on the spacecraft, in landing, and in the process of sample transfer to the appropriate facility for investigation. The "foam-in-the-capsule" system combines the effectiveness of encapsulation and flexibility to improve design according to new scientific data or changes in the capsule carrier's interior. The proposed system consists of a compliant outer restraint based upon the DoverPacREG system for containment of potent pharmaceutical powders and a foam-in-place encapsulation process. The decontamination foam will be effectively sealed within the inflatable polymer capsules. The dimensions of the capsules are variable to fit the dimensions of the sample to be encapsulated. Sterilization of the encapsulated sample container before opening through the incineration of the foam encapsulant is possible.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government